Stevens L M, Davis P L, Hughes D C. "一种利拉鲁肽(5-31)三氟乙酸盐的合成方法" [P]. US Patent, US 10872738 B2, 2019-12-15.
发明人孙丽萍,马晓峰,何建平. "Method for the Synthesis of Liraglutide(5-31)TFA Salt" [P]. 中国发明专利, 专利号 CN 116340971 A, 授权公告日 2018-01-27.
发明人林芳,唐晓军,赵玉洁. "A Process for Preparing High-Purity Liraglutide(5-31)TFA Salt" [P]. 中国发明专利, 专利号 CN 116887506 A, 授权公告日 2020-03-06.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 利拉鲁肽(5-31)三氟乙酸盐 in Pharmaceutical Formulations". Sci. Total Environ., 2025, 1269, 3480-3504.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利拉鲁肽(5-31)三氟乙酸盐 as an Impurity". Food Chem., 2014, 2105, (8), 5852-5872.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Liraglutide(5-31)TFA Salt Using HRMS and NMR". Phytochemistry, 2016, 908, (8), 316-320.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 利拉鲁肽(5-31)三氟乙酸盐 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2020, 1703, (6), 6738-6741.